Drug Metabolism and Pharmacokinetics

Supporting early drug discovery and late-stage drug development with state-of-the-art technologies.

With decades of experience in absorption, distribution, metabolism, and excretion (ADME) studies, the Resolian ADME team offers you expertise in the following in vitro studies: 

  • Metabolic stability in various matrices: e.g., plated hepatocytes and relay
  • Metabolite identification and profiling
  • Blood partitioning
  • Protein binding using equilibrium dialysis, ultracentrifugation and ultrafiltration
  • Reaction phenotyping (CYP and UGT)
  • Cell permeability
  • Hepatic uptake assays
  • Drug-Drug Interaction Studies
      • CYP induction
      • CYP inhibition (direct and time-dependent)
      • UGT inhibition
      • MAO inhibition
      • Drug transporter substrate and inhibition assays (uptake and efflux transporter studies using transfected cells and vesicles)

Reach out to us directly to learn more about Resolian’s Drug Metabolism and Pharmacokinetics services.

Our
Resources

Our Resources

Biomarker Assay List

Bioanalytical LC-MS/MS Assay List 

Immunoassay Pharmacokinetics

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now CEO at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.